Charles S. Grob, M.D.
Chief, Division of Child and Adolescent Psychiatry
Professor of Psychiatry and Pediatrics
1000 W. Carson Street
Torrance, CA 90509
Phone: (310) 222-3112
Fax: (310) 328-7217
Dr. Grob's clinical interests include mood and anxiety disorders, as well as the self-medication hypothesis of substance abuse as it applies to substance abuse. He has published in the professional literature on a variety of topics, including adolescent development and psychopathology, cross-cultural models of substance use and misuse and the history of hallucinogens in psychiatry. His research has included the first FDA approved Phase 1 study of the physiological and psychological effects of MDMA (3,4-methlyenedioxymethamphetamine), a multi-national, collaborative study of the Amazonian plant hallucinogen decoction, ayahuasca, in Brazil and a pilot investigation of the safety and efficacy of psilocybin in the treatment of anxiety in adult patients with advanced-stage cancer.
American Board of Psychiatry and Neurology
Internship, Internal Medicine, Pacific Medical Center, San Francisco, CA
Residency, Cedars-Sinai Medical Center, Los Angeles, CA
Fellowship, Family, Child and Adolescent Psychiatry, Cedars-Sinai Medical Center, Los Angeles, CA
Fellowship, Child Psychiatry, The Johns Hopkins Hospital, Baltimore, MD
M.D., State University of New York, Downstate Medical Center, Brooklyn, NY
B.S., Oberlin College and Columbia University
1. Grob, C.S. The enigma of ecstasy: implications for youth and society. Adolescent Psychiatry 29:97-117, 2005.
2. Grob, C.S. Revisiting hallucinogen research: an experimental model with advanced-stage cancer patients and anxiety. San Francisco Medicine 79(8):22- 23, 2006.
3. Walsh, R. and Grob, C.S. Early psychedelic investigators reflect on the psychological and social implications of their research. Journal of Humanistic Psychology 46:432-448, 2006.
4. Callaway, J.C, Grob, C.S, McKenna, D.J, Nichols, D.E, Shulgin, A. and Tupper, K.W. A demand for clarity regarding a case report on the injection of 5,-methoxy-N,N-dimethyltryptamine (5-MEO-DMT) in an ayahuasca preparation 30:406-407, 2006.
5. Grob, C.S. The use of psilocybin in patients with advanced cancer and existential anxiety: in Winkelman, M., and Roberts, T. (Eds.) Psychedelic Medicine: New Evidence for Hallucinogens as Treatments. Westport, CT, Praeger/Greenwood, vol. 1, pp.205-216, 2007.
6. Walsh, R. and Grob, C.S. Psychological health and growth: in Winkelman, M. and Roberts, T. (Eds.) Psychedelic Medicine: New Evidence for Hallucinogens as Treatments. Westport, CT: Praeger/Greenwood, vol. 2, pp. 213-225, 2007.
7. Grob, C.S. Substanz-unterstutzte psychotherapie am lebensende? Forschung mit
psilocybin bei krebspatienten im fortgenschrittenen stadium: in H. Jungaberle, P. Gasser, J. Weinhold and R. Verres (Eds.), Therapie mit Psychoaktiven Substanzen. Bern, Switzerland, Verlag Hans Huber, pp. 237-249, 2008.
8. Asarnow, J.R, Baraff, L.J, Berk, M, Grob, C.S, Devich-Navarro, M, Suddath, R, Piacentini, J. and Tang, L. Pediatric emergency department suicidal patients: two-site evaluation of suicide ideators, single attempters and repeat attempters. Journal of the American Academy of Child and Adolescent Psychiatry 47:958-966, 2008.
9. Grof, S, Grob, C, Bravo, G. and Walsh, R. Birthing the transpersonal. Journal of Transpersonal Psychology 40: 155-177, 2008.
10. Danforth, A.L. and Grob, C.S. Ecstasy: in G.L. Fisher and N.A. Roget (Eds.), Encyclopedia of Substance Abuse Prevention, Treatment and Recovery. London, U.K, Sage Publishers, pp. 352-354, 2009.
11. Dobkin de Rios, M. and Grob, C.S. The ritual use of psychoactive drugs: in I.P. Stolerman (Ed.), Encyclopedia of Psychopharmacology. Heidleberg, Germany, Springer Publishers, in press, 2009.
12. Griffiths, R.R. and Grob, C.S. Hallucinogens as medicine. Scientific American 303: 77-79, 2010.
13. Grob, C.S, Danforth, A.L, Chopra, G.S, Hagerty, M.C, McKay, C.R, Halberstadt, A.L. and Greer, G.R. Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. Archives of General Psychiatry 68(1):71-78, 2011.
14. Asarnow JR, Baraff LJ, Berk M, Grob CS, Devich-Navarro M, Suddath R, Piacentini JC, Rotheram-Borus MJ, Cohen D, Tang L. An emergency department intervention for linking pediatric suicidal patients to follow-up mental health treatment. Psychiatr Serv. 2011 Nov;62(11):1303-9. PMID: 22211209
15. Anderson BT, Labate BC, Meyer M, Tupper KW, Barbosa PC, Grob CS, Dawson A, McKenna D. Statement on ayahuasca. Int J Drug Policy. 2012 Mar 27. PMID: 22459485
PubMed Search for Charles S. Grob